| Dr James Brian Hoer, MD | |
|
4 Vanderbilt Park Drive, Suite 100, Asheville, NC 28803-1700 | |
| (828) 258-0397 | |
| (828) 258-3390 |
| Full Name | Dr James Brian Hoer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 4 Vanderbilt Park Drive, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255314092 | NPI | - | NPPES |
| 8944397 | Medicaid | NC | |
| 44397 | Other | NC | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | NC36734 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Margaret R Pardee Memorial Hospital | Hendersonville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Internal Medicine Associates Pa | 8426034422 | 26 |
News Archive
According to a senior health official in Indonesia three children have been hospitalized on suspicion of having the bird flu virus.
MRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV, the most common sexually transmitted infection in the United States. MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial.
Results of a recent survey of 13 pediatric hospitals in North America show a lack of universally applied standards for administering radiopharmaceutical doses to children undergoing nuclear medicine examinations, according to an article in the June issue of The Journal of Nuclear Medicine.
The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
› Verified 4 days ago
| Entity Name | Carolina Internal Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710058086 PECOS PAC ID: 8426034422 Enrollment ID: O20040629001069 |
News Archive
According to a senior health official in Indonesia three children have been hospitalized on suspicion of having the bird flu virus.
MRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV, the most common sexually transmitted infection in the United States. MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial.
Results of a recent survey of 13 pediatric hospitals in North America show a lack of universally applied standards for administering radiopharmaceutical doses to children undergoing nuclear medicine examinations, according to an article in the June issue of The Journal of Nuclear Medicine.
The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Brian Hoer, MD 4 Vanderbilt Park Drive, Suite 100, Asheville, NC 28803-1700 Ph: (828) 258-0397 | Dr James Brian Hoer, MD 4 Vanderbilt Park Drive, Suite 100, Asheville, NC 28803-1700 Ph: (828) 258-0397 |
News Archive
According to a senior health official in Indonesia three children have been hospitalized on suspicion of having the bird flu virus.
MRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV, the most common sexually transmitted infection in the United States. MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial.
Results of a recent survey of 13 pediatric hospitals in North America show a lack of universally applied standards for administering radiopharmaceutical doses to children undergoing nuclear medicine examinations, according to an article in the June issue of The Journal of Nuclear Medicine.
The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
› Verified 4 days ago
Dr. William R Harlan Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 191 Biltmore Ave, Asheville, NC 28801 Phone: 828-254-0881 Fax: 828-254-1614 | |
Dr. Nellie E. L. Fleming, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville Hospitalist Group, Asheville, NC 28801 Phone: 828-213-4411 Fax: 828-285-9740 | |
Dr. Wade H Saunders Iii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-277-6350 | |
Marianne Soufas, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 68 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-274-9567 Fax: 828-255-2865 | |
Dr. Bryan J Pace, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-274-6025 | |
Zachary Dillon Glenn, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Dr. Jeffrey Tyler Ramsey, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-407-2415 Fax: 828-412-4171 |